211 related articles for article (PubMed ID: 27774607)
1. Erythrocytosis in hepatocellular carcinoma portends poor prognosis by respiratory dysfunction secondary to mitochondrial DNA mutations.
Ke S; Chen S; Dong Z; Hong CS; Zhang Q; Tang L; Yang P; Zhai J; Yan H; Shen F; Zhuang Z; Wen W; Wang H
Hepatology; 2017 Jan; 65(1):134-151. PubMed ID: 27774607
[TBL] [Abstract][Full Text] [Related]
2. Gene expression of erythropoietin in hepatocellular carcinoma.
Muta H; Funakoshi A; Baba T; Uike N; Wakasugi H; Kozuru M; Jimi A
Intern Med; 1994 Jul; 33(7):427-31. PubMed ID: 7524823
[TBL] [Abstract][Full Text] [Related]
3. Prolyl-4-Hydroxylase 2 Potentially Contributes to Hepatocellular Carcinoma-Associated Erythrocytosis by Maintaining Hepatocyte Nuclear Factor-4α Expression.
Sun W; Kosyna FK; Jelkmann W; Depping R
Cell Physiol Biochem; 2015; 37(6):2257-64. PubMed ID: 26624507
[TBL] [Abstract][Full Text] [Related]
4. [Erythrocytosis in patients with hepatocarcinoma in alcoholic cirrhosis: ectopic production of erythropoietin?].
Giovanardi P; Sacchetti C; Cameroni P; Grandi M
Recenti Prog Med; 1998 May; 89(5):250-2. PubMed ID: 9676132
[TBL] [Abstract][Full Text] [Related]
5. Gene expression of mutant erythropoietin in hepatocellular carcinoma.
Funakoshi A; Muta H; Baba T; Shimizu S
Biochem Biophys Res Commun; 1993 Sep; 195(2):717-22. PubMed ID: 8396923
[TBL] [Abstract][Full Text] [Related]
6. [Paraneoplasic erythrocytosis].
Galiana Martín D; Suárez González A; Arias Miranda I; León Durán D
An Med Interna; 2005 Sep; 22(9):455-6. PubMed ID: 16397955
[No Abstract] [Full Text] [Related]
7. Erythrocytosis caused by an erythropoietin-producing hepatocellular carcinoma.
Matsuyama M; Yamazaki O; Horii K; Higaki I; Kawai S; Mikami S; Higashino M; Oka H; Nakai T; Inoue T
J Surg Oncol; 2000 Nov; 75(3):197-202. PubMed ID: 11088052
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma.
Hwang SJ; Lee SD; Wu JC; Chang CF; Lu CL; Tsay SH; Lo KJ
Zhonghua Yi Xue Za Zhi (Taipei); 1994 May; 53(5):262-9. PubMed ID: 7518732
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin gene expression in renal carcinoma is considerably more frequent than paraneoplastic polycythemia.
Wiesener MS; Münchenhagen P; Gläser M; Sobottka BA; Knaup KX; Jozefowski K; Jürgensen JS; Roigas J; Warnecke C; Gröne HJ; Maxwell PH; Willam C; Eckardt KU
Int J Cancer; 2007 Dec; 121(11):2434-42. PubMed ID: 17640059
[TBL] [Abstract][Full Text] [Related]
10. [A Case of Hepatocellular Carcinoma with Erythrocytosis].
Mitsuhashi N; Sai G; Shimizu Y; Sakai N; Suzuki D; Kuboki S; Furukawa K; Ohtsuka M
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1771-1773. PubMed ID: 36732994
[TBL] [Abstract][Full Text] [Related]
11. Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases.
Chu CW; Hwang SJ; Luo JC; Tsay SH; Li CP; Chang FY; Lee SD; Lui WY; Chiang JH
J Gastroenterol Hepatol; 1999 Aug; 14(8):807-10. PubMed ID: 10482434
[TBL] [Abstract][Full Text] [Related]
12. [Paraneoplastic syndrome of hepatocellular carcinoma].
Tagawa K; Uta Y
Ryoikibetsu Shokogun Shirizu; 1995; (7):453-5. PubMed ID: 8749523
[No Abstract] [Full Text] [Related]
13. Update on mutations in the HIF: EPO pathway and their role in erythrocytosis.
Lappin TR; Lee FS
Blood Rev; 2019 Sep; 37():100590. PubMed ID: 31350093
[TBL] [Abstract][Full Text] [Related]
14. [Erythrocytosis associated with hepatocellular carcinoma. Two case reports].
Argumanis E; Quispe D; Ruiz E
Rev Gastroenterol Peru; 2002; 22(1):84-7. PubMed ID: 11961573
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and erythropoietin receptor system in a large uterine myoma of a patient with myomatous erythrocytosis syndrome: possible relationship with the pathogenesis of unusual tumor size.
Pollio F; Staibano S; Mansueto G; De Rosa G; Persico F; De Falco M; Di Lieto A
Hum Pathol; 2005 Jan; 36(1):120-7. PubMed ID: 15712191
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic erythrocytosis as a primary presentation of hepatocellular carcinoma.
Chang PE; Tan CK
Indian J Med Sci; 2009 May; 63(5):202-3. PubMed ID: 19584492
[No Abstract] [Full Text] [Related]
17. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes.
Luo JC; Hwang SJ; Wu JC; Lai CR; Li CP; Chang FY; Chiang JH; Lui WY; Chu CW; Lee SD
Hepatogastroenterology; 2002; 49(47):1315-9. PubMed ID: 12239934
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin production in hepatocellular carcinoma cells associated with polycythemia: immunohistochemical evidence.
Sakisaka S; Watanabe M; Tateishi H; Harada M; Shakado S; Mimura Y; Gondo K; Yoshitake M; Noguchi K; Hino T
Hepatology; 1993 Dec; 18(6):1357-62. PubMed ID: 7694895
[TBL] [Abstract][Full Text] [Related]
19. Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (Where is/are the missing gene(s)?).
Bento C; Almeida H; Maia TM; Relvas L; Oliveira AC; Rossi C; Girodon F; Fernandez-Lago C; Aguado-Diaz A; Fraga C; Costa RM; Araújo AL; Silva J; Vitória H; Miguel N; Silveira MP; Martin-Nuñez G; Ribeiro ML
Eur J Haematol; 2013 Oct; 91(4):361-8. PubMed ID: 23859443
[TBL] [Abstract][Full Text] [Related]
20. The triad of hemochromatosis, hepatoma and erythrocytosis.
Raphael B; Cooperberg AA; Niloff P
Cancer; 1979 Feb; 43(2):690-4. PubMed ID: 217527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
